Thank you, Chair.
Vice-Chairs, members of the committee, thank you for inviting us to discuss the results of our study.
I would also like to thank you for your motion requesting the PBO to conduct a study on the costing of national pharmacare. It was certainly a challenge, but everyone on the team greatly appreciated the opportunity of working on such a study. It has certainly been a highlight among all our projects.
With your authorization, Mr. Chair, I would like to ask my colleague Carleigh Busby Malanik to make a short presentation on the main points of the report.
Thank you, Chair.